Old Web
English
Sign In
Acemap
>
Paper
>
THIRD-PARTY MESENCHYMAL STROMAL CELL THERAPY AND RISK OF ALLOSENSITISATION IN INTESTINAL TRANSPLANT PATIENTS
THIRD-PARTY MESENCHYMAL STROMAL CELL THERAPY AND RISK OF ALLOSENSITISATION IN INTESTINAL TRANSPLANT PATIENTS
2017
S Reddy
Georgios Vrakas
Mian Chen
Martin Barnardo
Philip Allan
F Dazzi
Peter J. Friend
Susan V. Fuggle
Keywords:
Immunology
Diabetes mellitus
Medicine
Stromal cell
Mesenchymal stem cell
Oncology
third party
Internal medicine
transplant patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]